Apheresis Equipment Market

The global Apheresis Equipment Market is valued at USD 3.85 Billion in 2024 and is projected to reach a value of USD 8.71 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 7.7% between 2025 and 2035. Market is driven by the rising demand for blood components for chronic diseases and technological advancements that improve procedure efficiency and effectiveness

Key Highlights

• By Product, the disposable apheresis kits segment accounted for the highest market share of 71.1% in 2024
• Based on the Applications, the Neurology category accounted for 49.1% of the market share in 2024
• North America dominated the market with 33.1% market share in 2024
• The increasing incidence of autoimmune and neurological disorders drives the demand for apheresis treatments
• Continuous equipment efficiency, safety, and automation advancements enhance treatment outcomes and attract healthcare providers

Major objectives of Apheresis Equipment Market Study:

• To gain a comprehensive understanding of the Apheresis Equipment market by identifying its key segments and subsegments
• To provide an in-depth analysis of the factors driving or hindering market growth, including emerging opportunities and challenges specific to the industry
• To analyze individual market segments for growth trends, future prospects, and their impact on the overall market
• To explore potential opportunities for stakeholders in the Apheresis Equipment market and to map out the competitive landscape of leading players
• To profile major companies within the market, evaluating their market share, strengths, and competitive advantages

Product Overview

The Product segment is divided into Disposable apheresis kits, and apheresis devices. The disposable apheresis kits segment held the dominant share in 2024, accounting for 71.1% share.

These single-use kits are pivotal because they minimize the risk of cross-contamination, ensuring higher safety and sterility during procedures. The increasing emphasis on infection control in healthcare settings has further driven demand, as these kits often include essential components such as tubing, filters, and collection bags, streamlining the apheresis process. Disposable kits' convenience and reliability contribute to their preference among healthcare providers, making them integral to the efficiency of apheresis treatments. As the market evolves, the growth of this segment is anticipated to continue, bolstered by advancements in manufacturing and design that enhance usability and patient safety.

Application Overview

The Application segment is separated into Renal Diseases, Hematology, Neurology, and Others.

In 2024, the Neurology segment held a 49.1% share in the Apheresis Equipment market. This segment is critical as apheresis plays a crucial role in treating neurological conditions such as Guillain-Barré Syndrome and Multiple Sclerosis, where the procedure helps to remove disease-causing antibodies and immune cells that trigger inflammation and nerve damage. The considerable share reflects growing clinical recognition of apheresis as an effective therapeutic option in neurology, particularly amid rising cases of autoimmune neurological disorders, which have been increasingly prevalent in recent years. The expansion of therapeutic applications within this segment is expected to continue, driven by advancements in apheresis technology and an expanding patient population requiring specialized care.

Regional Overview

In 2024, the North America, captured 33.1% of the revenue share

​The Apheresis Equipment Market in North America is the largest globally, driven by a robust healthcare infrastructure and a high adoption rate of innovative medical technologies.​ The increasing prevalence of autoimmune disorders, blood cancers, and neurological diseases is driving the demand for apheresis procedures. This region emphasizes technological innovation, enhancing automation and equipment efficiency. Furthermore, regulatory bodies in the U.S. and Canada support new technology introductions, driving an environment conducive to growth.

The Asia Pacific region is recognized as the fastest-growing market for Apheresis Equipment, with expectations of significant growth over the coming years. The regions rapid expansion can be attributed to a rising prevalence of chronic diseases, including cardiovascular issues and increased incidence of blood-related conditions. Additionally, continuous advancements in apheresis technology and supportive healthcare policies promote the adoption of apheresis procedures across various healthcare facilities in the region.

Europes Apheresis Equipment Market is also experiencing notable growth, primarily driven by the increasing prevalence of chronic diseases and favorable healthcare policies. The aging population within Europe significantly impacts the demand for therapeutic apheresis, as older individuals are more susceptible to health conditions requiring such interventions. Collaborations among prominent industry players further enhance innovation, leading to a broader application range of apheresis technologies in treating emerging medical challenges.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Key Trends

1. Technological Advancements: Technological innovations in Apheresis Equipment are rising, with significant improvements in automation and real-time monitoring capabilities. Companies are launching next-generation devices that enhance efficiency and safety, such as the Fresenius APRΞD platform, which boasts advanced software for better process control.
2. Rising Demand Due to Demographic Changes: The aging population and the increasing incidence of chronic diseases contribute to a higher demand for apheresis procedures. Conditions like blood-related illnesses prompt healthcare providers to seek efficient blood component collection methods.
3. Focus on Personalized Medicine: Advancements in apheresis technology allow personalized treatment options that cater to patient needs. This customization improves the overall patient experience and outcomes, driving the demand for advanced apheresis devices.
4. Automated Blood Collection Growth: There has been a notable rise in automated blood collection systems, which streamline the collection process and ensure donor safety. These systems dramatically improve efficiency, reducing procedural times and enhancing the collection of multiple blood components in one session.
5. Environmental Sustainability: The market is witnessing a shift towards using disposable kits in apheresis procedures to minimize the risk of infection and improve safety. This trend supports sustainability goals by reducing the cleaning and sterilization demands of reusable equipment.

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Definition

Apheresis is a medical procedure that involves using a specialized machine to separate, extract, and collect specific blood components, such as plasma, platelets, or red blood cells. Apheresis Equipment refers to the machines designed for this purpose. These machines use centrifugal and filtration techniques to isolate these components effectively while returning the remaining blood to the donor or patient.

Market Dynamics

Technological Advancements Such as Automated Blood Collection Systems and Improved Monitoring Technologies Drive Market Expansion

​

Higher Equipment Cost and Regulatory Challenges Impact Market Accessibility

However, the market faces several restraints that may hinder its growth trajectory. The high initial costs of purchasing sophisticated Apheresis Equipment, often exceeding USD 100,000 per unit, present a barrier for smaller healthcare facilities and clinics. Moreover, stringent regulatory requirements can extend the time it takes to bring new products to market, with over 70% of manufacturers noting that navigating these regulatory landscapes reduces product launch timelines. The shortage of qualified personnel trained to operate these advanced devices also affects procedural efficiency, as approximately 20% of apheresis centers struggle to find adequately trained staff, leading to longer patient wait times and lower throughput.

Emerging Therapeutic Applications and Regional Developments Driving Market Opportunities

Growth opportunities are generated by the increasing use of apheresis in emerging therapeutic applications, especially in treating autoimmune diseases and genetic disorders. The shift towards personalized medicine is paving the way for tailored apheresis therapies, which enhance treatment effectiveness. Furthermore, the Asia Pacific region is developing rapidly, bolstered by healthcare policy shifts favoring advanced medical technologies. Increased investments in healthcare infrastructure are anticipated to promise further growth in this region, characterized by a burgeoning patient population demanding modern therapeutic solutions. This trend provides an opening for manufacturers to introduce innovative apheresis technologies and expand their market presence in these rapidly evolving landscapes.

Competitive Landscape

​The Apheresis Equipment Market is highly competitive, with significant players like Fresenius Kabi, Terumo BCT, and Haemonetics leading innovation and market share. ​Fresenius Kabis APRΞD platform and Terumo BCTs Spectra Optia system are at the forefront of technological advancements, contributing to a collective increase of approximately 12% in their respective market shares by 2024.​ These companies invested around USD 150 million in research and development in 2023 to enhance their products' automation, efficiency, and safety features. Additionally, emerging entrants are capturing attention with novel approaches, such as 3D-printed disposable kits, which are projected to see demand growth of over 20% in the near term. Strategic partnerships further drive this competitive environment to align with the latest therapeutic trends and expand market reach.

Recent Market Developments

TERUMO BCT, INC. Launches Training Program for Cell and Gene Therapy Manufacturers

• In May 2023, TERUMO BCT, INC. launched the first training program initiative aimed at supporting cell and gene therapy manufacturers. This program focuses on improving cell collection processes and boosting the commercialization of therapeutics.

Fresenius Kabi AG and Lupagen Inc. Enter Supply and Development Agreement

• In August 2023, Fresenius Kabi AG and Lupagen Inc. entered into a supply and development agreement for technologies designed to bring cell and gene therapies directly to the bedside. This collaboration highlights the industrys strategic efforts to strengthen market positions and drive innovation.

FDA Clears TERUMO BCT, INC.’s Platelet Device

• In August 2023, TERUMO BCT, INC. received clearance from the U.S. FDA for a new platelet device that processes blood into platelets in a single centrifugation cycle. This clearance marks a significant advancement in blood processing technology.

The global Apheresis Equipment market can be categorized as Product, Procedure, Technology, Application, End User and Region.